CD8A and neoplasm: Indeed, inflamed tumor cells (PDL1+ MHCI+), CD8+ T cells, and Ki67+ tumor cells were identified as the three most important cell-type percentages that could predict treatment group (Figure 4C, AUC = 0.95).